Heron Therapeutics logo
Heron Therapeutics HRTX
$ 1.07 -4.91%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Heron Therapeutics Financial Statements 2011-2024 | HRTX

Annual Financial Statements Heron Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

326 M 206 M 858 K 1.58 B 1.75 B 1.97 B 1.23 B 476 M 694 M 210 M 191 M 193 M 33.7 M

Shares

138 M 109 M 98.5 K 90.8 M 81.8 M 73.2 M 54 M 37.9 M 33.1 M 26.6 M 16.2 M 12.2 M 6.01 M

Historical Prices

2.36 1.89 8.71 17.4 20.9 26.9 21.6 13 21 7.9 12.2 16.2 5.6

Net Income

-111 M -182 M -221 M -227 M -205 M -179 M -197 M -173 M -97.6 M -76.4 M -55.3 M -23.3 M -11.8 M

Revenue

127 M 108 M 86.3 M 88.6 M 146 M 77.5 M 30.8 M 1.28 M - - - - 646 K

Cost of Revenue

65.1 M 54.9 M 46 M 36.2 M 61.6 M 27.5 M 4.59 M 35 K - - - - -

Gross Profit

61.9 M 52.8 M - 52.4 M 84.3 M 50 M 26.2 M 1.24 M - - - - 646 K

Operating Income

-111 M -175 M -218 M -228 M -211 M -184 M -195 M -171 M -96.9 M -74.6 M -54.5 M -23.8 M -11.1 M

Interest Expense

3.87 M 2.47 M 2.41 M 1.9 M 1.47 M 2.67 M 3.94 M 2.66 M 958 K 887 K 828 K 605 K -

EBITDA

-108 M -172 M -215 M -225 M -209 M -182 M -193 M -170 M -96.2 M -74 M -54.1 M -23.6 M -10.9 M

Operating Expenses

- - - 281 M 295 M 234 M 221 M 172 M 96.9 M 74.6 M 54.5 M 23.8 M 11.7 M

General and Administrative Expenses

49 M 37.4 M 40.2 M 42.2 M 37.9 M 29.3 M 25.6 M 21.4 M 35.7 M 19.7 M 21.7 M 8.79 M 3.5 M

All numbers in USD currency

Quarterly Income Statement Heron Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

153 M 152 M 151 M 145 M 120 M 119 M - 112 M 102 M 102 M 102 M 102 M 98.5 M 91.4 M 91.3 M 90.8 M 90.8 M 90.4 M 90.3 M 79.9 M 79.5 M 78.4 M 78.2 M 77.8 M 72 M 64.7 M 64.6 M 54.2 M 53.8 M 50.5 M 39.4 K 39.1 M 37 M 36.2 M 36.1 M 35.8 M 31 M 29.4 M 29.2 M 29 M 24.3 M 23.7 M 23.6 M 15.4 M 15.3 M 15.3 M 15.1 M 274 M 200 K 200 M 200 M - - -

Net Income

-4.85 M -9.24 M -3.16 M -25 M -42.1 M -32.8 M - -41.9 M -56.4 M -63.9 M - -52.4 M -61 M -52.6 M -62.3 M -58.2 M -55.2 M -51.6 M -57.9 M -33.6 M -50.2 M -63 M -49.6 M -38.3 M -38.7 M -52.3 M -62.5 M -41.9 M -42.8 M -50.3 M -48 M -48.5 M -43.2 M -33.4 M -31.2 M -22.7 M -23.1 M -20.6 M -20.6 M -19.2 M -19 M -17.5 M -14 M -12.9 M -15.4 M -13 M -7.74 M -6.12 M -4.57 M -13 M -4.26 M -4.2 M -1.93 M -1.42 M

Revenue

32.8 M 36 M 34.7 M 31.4 M 31.8 M 29.6 M - 26.6 M 27.6 M 23.5 M - 23.2 M 22.4 M 20 M 20.6 M 20 M 22.7 M 25.4 M 35.1 M 42.6 M 36.7 M 31.6 M 28.8 M 19.8 M 17.3 M 11.6 M 10.1 M 8.57 M 8.51 M 3.63 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

9.46 M 10.5 M 8.44 M 18.2 M 20.2 M 16.9 M - 14.7 M 16.2 M 11.4 M - 11.4 M 14.5 M 9.21 M 9.39 M 7.17 M 9 M 10.6 M 15.9 M 17.2 M 13.6 M 15 M 11.6 M 7.58 M 5.23 M 3.13 M 1.34 M 1.05 M 1.01 M 1.19 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

23.4 M 25.5 M 26.2 M 13.2 M 11.6 M 12.8 M - 11.8 M - - - - - - 11.2 M 12.8 M 13.7 M 14.8 M 19.2 M 25.4 M 23.1 M 16.6 M 17.3 M 12.2 M 12 M 8.43 M 8.72 M 7.52 M 7.5 M 2.45 M 1.24 M - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-4.46 M -6.44 M -4.8 M -24.9 M -42.4 M -33.1 M - -41.9 M -49.5 M -62.9 M - -51.7 M -60.5 M -52.1 M -61.3 M -58.4 M -55.7 M -52.7 M -59.4 M -34.9 M -51.8 M -64.7 M -51.3 M -41.8 M -38.9 M -52 M - -41.3 M -42.1 M -49.3 M - -47.7 M -43.1 M -33.3 M - -22.5 M -23 M -20.4 M - -19 M -18.8 M -17.3 M - -12.7 M -15.2 M -12.8 M - -6.05 M -4.38 M -4.77 M - -4.09 M -1.54 M -1.32 M

Interest Expense

-390 K -2.79 M 1.64 M -79 K 344 K 295 K - -26 K -6.86 M -965 K - -700 K -546 K -500 K - 156 K 559 K 1.16 M - 1.26 M 1.56 M 1.69 M - 3.43 M 183 K -275 K -600 K -552 K -744 K 1.03 M 1.27 M 886 K 257 K 133 K 247 K 242 K 237 K 232 K 227 K 224 K 220 K 216 K 212 K 209 K 205 K 201 K - - - 202 K - - - -

EBITDA

- - -4.11 M - - -32.3 M - -39.8 M -48.1 M -62.2 M - -49.5 M -59 M -51.4 M -61.3 M -56.2 M -54.4 M -52.1 M -59.4 M -33.4 M -50.8 M -64.2 M -51.3 M -40.7 M -38.1 M -51.6 M - -40.2 M -41.3 M -49 M - -46.9 M -42.6 M -33.1 M - -22 M -22.7 M -20.2 M - -18.6 M -18.6 M -17.2 M - -12.4 M -15.1 M -12.7 M - -5.91 M -4.29 M -4.72 M - -3.95 M -1.45 M -1.27 M

Operating Expenses

- - - - - - - - - - - - - - - - - - - - - 96.3 M - 61.6 M 56.1 M 63.6 M - 49.9 M 50.6 M 52.9 M - 47.7 M 43.1 M 33.3 M - 22.5 M 23 M 20.4 M - 19 M 18.8 M 17.3 M 13.8 M 12.7 M 15.2 M 12.8 M 8.63 M 6.05 M 4.38 M 4.77 M 4.12 M 4.09 M 1.79 M 1.71 M

General and Administrative Expenses

12.4 M 13.9 M 15 M 15.9 M 19.6 M 15.8 M - 9.8 M 9.18 M 9.53 M - 9.79 M 10.9 M 9.57 M 12.5 M 9.48 M 9.82 M 10.4 M 9.87 M 8.6 M 9.78 M 9.65 M 8.74 M 7.29 M 6.21 M 7.03 M 6.16 M 6.46 M 6.18 M 6.74 M 5.89 M 5.33 M 4.77 M 5.37 M 6.6 M 4.13 M 4.08 M 3.59 M 5.3 M 4.22 M 4.51 M 5.69 M 5.29 M 6.5 M 4.46 M 5.61 M - 2.43 M 1.31 M 5.69 M - 1.16 M 509 K 569 K

All numbers in USD currency